Uncommon Cents Investing LLC reduced its stake in Plexus Corp. (NASDAQ:PLXS) by 5.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,115 shares of the technology company’s stock after selling 660 shares during the period. Uncommon Cents Investing LLC’s holdings in Plexus were worth $1,113,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Veriti Management LLC bought a new stake in Plexus during the 4th quarter worth approximately $78,000. Signaturefd LLC grew its holdings in shares of Plexus by 19.3% during the fourth quarter. Signaturefd LLC now owns 1,012 shares of the technology company’s stock worth $79,000 after purchasing an additional 164 shares in the last quarter. Vantage Consulting Group Inc bought a new position in shares of Plexus in the fourth quarter worth approximately $101,000. Sowell Financial Services LLC raised its position in shares of Plexus by 20.3% during the 4th quarter. Sowell Financial Services LLC now owns 2,328 shares of the technology company’s stock valued at $182,000 after buying an additional 393 shares in the last quarter. Finally, Crawford Investment Counsel Inc. purchased a new position in Plexus in the fourth quarter worth $207,000. 94.15% of the stock is currently owned by institutional investors and hedge funds.
PLXS stock traded down $2.52 during trading on Thursday, hitting $90.91. 2,103 shares of the company traded hands, compared to its average volume of 145,946. The firm has a market capitalization of $2.62 billion, a PE ratio of 23.83 and a beta of 1.18. Plexus Corp. has a 1 year low of $54.31 and a 1 year high of $96.27. The company has a 50-day moving average of $90.73 and a 200-day moving average of $80.99. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.01 and a current ratio of 1.77.
Several equities research analysts have issued reports on the company. Needham & Company LLC lifted their price target on Plexus from $77.00 to $89.00 and gave the stock a “buy” rating in a research note on Friday, January 22nd. Sidoti lowered Plexus from a “buy” rating to a “neutral” rating and set a $94.00 target price for the company. in a research note on Wednesday, March 31st. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $84.17.
In other news, CEO Todd P. Kelsey sold 4,443 shares of the business’s stock in a transaction that occurred on Friday, February 12th. The stock was sold at an average price of $82.78, for a total transaction of $367,791.54. Also, VP Ronnie Darroch sold 3,637 shares of the firm’s stock in a transaction on Monday, January 25th. The stock was sold at an average price of $80.23, for a total value of $291,796.51. Following the completion of the sale, the vice president now directly owns 13,531 shares of the company’s stock, valued at approximately $1,085,592.13. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,763 shares of company stock valued at $1,823,824. Insiders own 2.38% of the company’s stock.
Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Story: Non-Fungible Token (NFT)
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.